Daniel Rea

Publications

  1. Published
  2. Published
  3. Published
  4. Published

    A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first line therapy for advanced colorectal cancer

    Daniel Rea, , , , , , , , , Neil Steven, , & , 25 May 2005, In: Annals of Oncology. 16, 7, p. 1123-1132 10 p.

    Research output: Contribution to journalArticle

  5. Published
  6. Published

    Acute non-myelosuppressive complications of systemic anticancer therapy

    Daniel Rea, 1 Aug 2008, In: Clinical Medicine. 8, 4, p. 439-442 4 p.

    Research output: Contribution to journalEditorial

  7. Published
  8. Published

    Addressing overtreatment of screen detected DCIS; the LORIS trial

    Toon Brookes, Tracy Roberts, Sarah Pirrie, Lucinda Billingham & 2 others, Sarah Bowden & Daniel Rea, Nov 2015, In: European Journal of Cancer. 51, 16, p. 2296-2303 8 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer

    Daniel Rea, 1 Jan 2004, In: Therapy. 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

  10. Published
  11. Published

    Adjuvant tamoxifen: How long before we know how long?

    Daniel Rea, Christopher Poole & Richard Gray, 16 May 1998, In: BMJ. 316, 7143, 1 p.

    Research output: Contribution to journalArticlepeer-review

  12. Published

    Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

    Daniel Rea, , , , , , , , , , , , , , & , 1 Jan 2011, In: Lancet. 377, 9762, p. 321-331 11 p.

    Research output: Contribution to journalArticle

  13. E-pub ahead of print

    Adjuvant tamoxifen and exemestane in postmenopausal early breast cancer: ten-year analysis of the randomised phase III TEAM trial

    Daniel Rea, , , , , & , 18 Jul 2017, (E-pub ahead of print) In: The Lancet Oncology.

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. Published

    Antibacterial prophylaxis after chemotherapy for solid tumours and lymphomas

    Neil Steven, Lucinda Billingham, , , , , Daniel Rea, , , & , 8 Sep 2005, In: New England Journal of Medicine. 353, 10, p. 988-998 11 p.

    Research output: Contribution to journalArticle

  16. Published

    Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

    Richard Gray & , 3 Oct 2015, In: The Lancet. 386, 10001, p. 1341-1352 12 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published
  18. Published
  19. Published
  20. Published

    Breast screening saves lives: Now is the time to address overtreatment

    Daniel Rea & , 2014, In: Journal of Comparative Effectiveness Research. 3, 2, p. 111-113 3 p.

    Research output: Contribution to journalEditorialpeer-review

  21. Published

    Cardiac safety of simultaneous anti-HER2 and anthracycline therapy

    Mariam Jafri & Daniel Rea, Feb 2016, In: Breast Cancer Management. 5, 1, p. 21-29

    Research output: Contribution to journalArticlepeer-review

  22. E-pub ahead of print

    Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

    Daniel Rea & 1 others, , 26 May 2017, (E-pub ahead of print) In: Modern Pathology. 30, p. 1069-1077

    Research output: Contribution to journalArticlepeer-review

  23. Published

    Chemotherapy for advanced colorectal cancer

    Daniel Rea, 1 Jan 2003, In: Colonews. 1, p. 3-6 4 p.

    Research output: Contribution to journalArticle

  24. Published

    Chemotherapy for epithelial ovarian cancer: An update

    Daniel Rea & Christopher Poole, 1 Jan 1997, In: Current Obstetrics and Gynaecology. 7, 1, p. 50-60 11 p.

    Research output: Contribution to journalReview articlepeer-review

  25. Published

    Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

    Daniel Rea & 8 others, , , , , , , & , Oct 2020, In: The Lancet Oncology. 21, 10, p. 1296-1308 13 p.

    Research output: Contribution to journalArticlepeer-review

  26. Published

    Coagulopathic complications in breast cancer

    Paul Stonelake, Daniel Rea & Gregory Lip, 15 Oct 2003, In: Cancer. 98, p. 1578-1586 9 p.

    Research output: Contribution to journalArticle

  27. E-pub ahead of print

    Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study

    Daniel Rea, Dec 2021, In: Breast Cancer. 7, 1, 13 p., 90.

    Research output: Contribution to journalArticlepeer-review

  28. Published
  29. Published

    Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013

    Daniel Rea, & , 1 Oct 2016, In: Cancer Epidemiology. 44, p. 186-194 9 p.

    Research output: Contribution to journalArticlepeer-review

  30. Published

    Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training

    3 Sep 2020, In: PLoS ONE. 15, 9 September, e0238593.

    Research output: Contribution to journalArticlepeer-review

  31. Published
  32. Published

    Dietary phytoestrogens influence susceptibility to breast cancer by inhibiting sulphotransferase enzymes?

    Chris Kirk, , , Philip Hughes, , Daniel Rea & Rosemary Waring, 1 Jan 2001, p. 82. 1 p.

    Research output: Contribution to conference (unpublished)Paper

  33. Published
  34. Published
  35. Published

    Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

    Daniel Rea, 29 Oct 2013, In: British Journal of Cancer. 109, 9, p. 2453-2461 9 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published

    Ductal carcinoma in situ: to treat or not to treat, that is the question

    Daniel Rea, 13 Aug 2019, In: British Journal of Cancer. 121, 4, p. 285-292 8 p.

    Research output: Contribution to journalReview articlepeer-review

  37. Published
  38. E-pub ahead of print

    Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

    & 2 others, Daniel Rea & , Dec 2021, In: Breast Cancer. 7, 1, 8 p., 74.

    Research output: Contribution to journalArticlepeer-review

  39. Published
  40. Published

    Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: A Tamoxifen Exemestane Adjuvant Multinational Study Analysis

    Daniel Rea, , , , , , , & , 1 Feb 2013, In: Oncologist. 18, 1, p. 8-13 6 p.

    Research output: Contribution to journalArticlepeer-review

  41. Published
  42. Published

    Endocrine therapy for early breast cancer

    Syed Hussain, , & Daniel Rea, 1 Oct 2004, In: Expert Review of Anticancer Therapy. 4, p. 877-888 12 p.

    Research output: Contribution to journalArticle

  43. Published
  44. Published
  45. Published
  46. E-pub ahead of print
  47. Published
  48. Published

    From basic science to clinical practice: innovations in cancer therapy.

    Daniel Rea, 1 Dec 1998, In: Hospital medicine (London, England : 1998). 59, 12, p. 918-919 2 p.

    Research output: Contribution to journalEditorialpeer-review

  49. Published

    Genomics and pharmacogenomics in the management of breast cancer

    Jennifer Pascoe, Daniel Palmer, , Daniel Rea & Syed Hussain, 1 Mar 2009, In: Current Pharmacogenomics. 6, 1, p. 45-55 11 p.

    Research output: Contribution to journalArticle

  50. Published
Previous 1 2 3 Next